XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (6,004,833) $ (5,624,064)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 177,255 485,277
Loss on write-off of property and equipment 5,212  
Unrealized gain on change in fair value of warrants classified as a liability (312,430) (4,404,000)
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification   394,000
Transaction costs allocated to warrant liabilities   633,198
Loss on issuance of warrants   1,633,767
Stock-based compensation 55,484 511,709
Change in provision for bad debts 5,423  
Change in operating assets and liabilities:    
Accounts receivable (423,297) (153,350)
Inventories 89,726 (5,916)
Prepaid expenses, other current assets and deposits 247,572 (81,043)
Accounts payable and accrued liabilities (394,721) (332,100)
Deferred revenue 43,500 (25,150)
Net cash used in operating activities (6,511,109) (6,967,672)
Cash flows from investing activities:    
Purchase of property and equipment (302,198) (14,828)
Net cash used in investing activities (302,198) (14,828)
Cash flows from financing activities:    
Net proceeds from exercise of warrants 1,492,772  
Net proceeds from issuance of common stock 5,712,700 2,980,340
Net cash provided by financing activities 7,205,472 2,980,340
Net increase (decrease) in cash, cash equivalents and restricted cash 392,165 (4,002,160)
Cash, cash equivalents and restricted cash at beginning of period 7,181,095 7,901,800
Cash, cash equivalents and restricted cash at end of period 7,573,260 3,899,640
Non-cash investing and financing activities:    
Transaction costs included in accounts payable   111,747
Deemed dividend warrant modifications 38,826,652 $ 233,087
Warrants issued, cashlessly 5,141  
Property and equipment acquired and included in accounts payable $ 10,923